Trinity Life Sciences is a strategic, tech-enabled commercialization company that supports pharmaceutical, biotech, and medtech organizations in developing, launching, and optimizing medical innovations. Founded in 1996, the firm has nearly three decades of industry experience and serves over 350 customers across North America, Europe, Latin America, and Asia Pacific.
The company's work sits at the intersection of artificial intelligence, analytics, real-world evidence, and technology platforms. It has been involved in approximately 70% of all new drug launches and reports the ability to predict up to 90% of revenue outcomes for its clients. Trinity combines human expertise with AI-driven approaches to deliver evidence-based solutions across the life sciences commercialization lifecycle.
Its proprietary technology platforms include TrinityEDGE™ and InsightsEDGE™, both designed to support life sciences commercialization. These tools underpin the company's consulting and analytics services, enabling data-driven decision-making for drug development and market strategy.
